C. R. Bard and Proseed
C.R. Bard Inc., a multinational medical device company, agreed to pay the federal government $48.2 million to settle this whistleblower lawsuit that alleged its urological division and wholly owned subsidiary, ProSeed Inc., paid doctors and hospitals kickbacks to entice them to order Bard’s products at inflated prices to treat Medicare patients with prostate cancer.
C.R. Bard Inc., and Proseed, Inc. agreed to pay the federal government $48.2 million to settle this whistleblower lawsuit.
Articles and Links:
- Wilbanks & Gouinlock Client Settles Whistleblower Case With $48 Million Settlement
Click Here for Daily Report dated Wednesday May 15, 2013.
- Adventist Repays Millions To Medicare
Click Here for Orlando Sentinel article by Marni Jameson dated March 6, 2013.
- Adventist Health Can’t Dodge FCA Claim Of ER Overbilling
Click Here for Law 360 article dated February 20, 2013.
- Whistleblower Lawsuit Alleges Adventist Hospital Filed Millions In False Claims
Click here for Orlando Sentinel Article dated August 8, 2012.